Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Mellor

Showing results (11-20 of 229) with videos related to

Pageof 23
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2011
Physiologic control of the functional status of Foxp3+ regulatory T cellsAndrew L Mellor, David H Munn
The Journal of Clinical Investigation|May 4, 2007
Indoleamine 2,3-dioxygenase and tumor-induced toleranceDavid H Munn, Andrew L Mellor
Annual Review of Immunology|June 3, 2000
Immunology at the maternal-fetal interface: lessons for T cell tolerance and suppressionA L Mellor, D H Munn
Nature Reviews. Immunology|October 2, 2004
IDO expression by dendritic cells: tolerance and tryptophan catabolismAndrew L Mellor, David H Munn
Trends in Immunology|October 30, 2012
Indoleamine 2,3 dioxygenase and metabolic control of immune responsesDavid H Munn, Andrew L Mellor
Journal of Reproductive Immunology|October 16, 2001
Tryptophan catabolism prevents maternal T cells from activating lethal anti-fetal immune responsesA L Mellor, D H Munn
Immunology Today|September 29, 1999
Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?A L Mellor, D H Munn
Nature Reviews. Immunology|December 8, 2007
Creating immune privilege: active local suppression that benefits friends, but protects foesAndrew L Mellor, David H Munn
Trends in Immunology|February 4, 2016
IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and ToleranceDavid H Munn, Andrew L Mellor
Frontiers in Immunology|November 23, 2017
Indoleamine 2,3-Dioxygenase and Tolerance: Where Are We Now?Andrew L Mellor, Henrique Lemos, Lei Huang
Pageof 23

Showing results (11-20 of 229) with videos related to

Sort By:
Pageof 23
Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2011
Physiologic control of the functional status of Foxp3+ regulatory T cellsAndrew L Mellor, David H Munn
The Journal of Clinical Investigation|May 4, 2007
Indoleamine 2,3-dioxygenase and tumor-induced toleranceDavid H Munn, Andrew L Mellor
Annual Review of Immunology|June 3, 2000
Immunology at the maternal-fetal interface: lessons for T cell tolerance and suppressionA L Mellor, D H Munn
Nature Reviews. Immunology|October 2, 2004
IDO expression by dendritic cells: tolerance and tryptophan catabolismAndrew L Mellor, David H Munn
Trends in Immunology|October 30, 2012
Indoleamine 2,3 dioxygenase and metabolic control of immune responsesDavid H Munn, Andrew L Mellor
Journal of Reproductive Immunology|October 16, 2001
Tryptophan catabolism prevents maternal T cells from activating lethal anti-fetal immune responsesA L Mellor, D H Munn
Immunology Today|September 29, 1999
Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?A L Mellor, D H Munn
Nature Reviews. Immunology|December 8, 2007
Creating immune privilege: active local suppression that benefits friends, but protects foesAndrew L Mellor, David H Munn
Trends in Immunology|February 4, 2016
IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and ToleranceDavid H Munn, Andrew L Mellor
Frontiers in Immunology|November 23, 2017
Indoleamine 2,3-Dioxygenase and Tolerance: Where Are We Now?Andrew L Mellor, Henrique Lemos, Lei Huang
Pageof 23